3D Bioprinting Market 2030 By Component (3D Bioprinters and Bioinks), Technology (Stereolithography, Selective Laser Sintering, Electron Beam Melting, Fused Deposition Modeling, Laminated Object Manufacturing, Inkjet Printing and Multi-phase Jet Solidification), Material Type (Living Cells, Extracellular Matrices and Hydrogels), Application (Surgical Simulation and Training Models, Regenerative Medicine, Medical Sensors and Others), End-user (Research Organizations & Academic Institutes and Others) and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 180 Pages | Published On : Dec 2023

         
     

3D Bioprinting Market was valued USD 2.3 Billion in 2023 and projected to reach USD 6.9 Billion by 2030, growing at a CAGR of 16.7% during the forecast period of 2023-2030.

3D Bioprinting Market Size


Graph
             2019                         2023-2030      

ReportDetails
Market Size ValueUSD 2.3 Billion in 2023
Market Size ValueUSD 6.9 Billion by 2030
CAGRCAGR of 16.7%
Forecast Period2023-2030
Historic Data2019
Segments CoveredTechnology, Component, Material Type, Application, End-user and Region
Geographics CoveredNorth America, Europe, Asia Pacific, and RoW

Major vendors in the global 3D bioprinting market : Envisiontec, Inc., Organovo, Inventia Life Science Pty Ltd, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L., BICO Group AB, Organovo Holdings Inc., CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd., Advanced Solutions Life Sciences, LLC, Regenovo Biotechnology Co., Ltd. and Others.

Market Overview

The global 3D bioprinting market is experiencing substantial growth, propelled by the convergence of technological advancements and expanding applications in healthcare and biotechnology. This cutting-edge technology enables precise layer-by-layer deposition of biomaterials and living cells, forming three-dimensional structures that replicate the intricacy of human tissues and organs. The market's expansion is driven by an increasing demand for personalized medicine, solutions for organ transplantation, and progress in regenerative medicine. The healthcare sector, in particular, stands to benefit significantly from 3D bioprinting, as it has the potential to transform drug testing, disease modeling, and the creation of patient-specific implants. With escalating research and development efforts, collaborations among academia, research institutions, and industry stakeholders are on the rise. Despite persistent regulatory challenges, ongoing initiatives to establish standards and guidelines contribute to the market's maturation. The global 3D bioprinting market holds the promise of addressing crucial medical challenges and enhancing patient outcomes, positioning itself for sustained growth in the foreseeable future.

3D bioprinting is experiencing a growing presence within the cosmetics and pharmaceutical industries

3D bioprinting is experiencing a growing presence within the cosmetics and pharmaceutical industries. Numerous pharmaceutical companies are swiftly adopting 3D bioprinting technologies and products to expedite the discovery and development of novel drugs. In comparison to traditional drug testing methods, 3D bioprinting offers a more cost-effective and secure approach for drug evaluation. By leveraging the 3D bioprinting approach, pharmaceutical firms can assess the effectiveness of medications in a matter of hours, significantly reducing the typical three to six years required for new drug development. This innovative technique empowers research and development teams to test new medications both in early stages and during preclinical studies using 3D bioprinted tissues. The benefits encompass a decrease in reliance on animal testing, heightened efficiency, and an accelerated drug development process. The growing utilization of 3D printing is fostering a deeper understanding of this technology, particularly in the cosmetics domain. Moreover, spurred by the European Commission's prohibition of animal testing for cosmetics since March 2013, various enterprises in the cosmetics and healthcare sectors are embracing 3D bioprinting to establish cutting-edge 3D tissue models and methodologies for drug screening.

Market Dynamics

Drivers:

  • Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries
  • Developments in 3D bioprinting for tissue and organ regeneration applications
  • Rising public and private funding to support bioprinting research activities
  • Technological advancements in 3D bioprinting industry

Opportunities:

  • Rising demand for organ transplant
  • Growing awareness of 3D bioprinting
  • Growing demand for regenerative medicine and stem cell research

Rising demand for organ transplants

The realm of 3D bioprinting is experiencing rapid expansion within the medical sector. This innovative process involves generating living tissues and organs based on computer-aided design models. Its potential to transform medical treatments is remarkable. By offering the capability to tackle the escalating demand for organ transplants, which currently surpasses the availability of donor organs, 3D bioprinting could usher in a revolutionary approach. This technology presents an ethical and efficient avenue for crafting organs suitable for transplantation. Furthermore, it holds the promise of curtailing the expenses linked with organ transplant procedures. As advancements continue to refine this technology, the 3D bioprinting market is anticipated to witness substantial growth in the years to come.

The market for 3D Bioprinting is dominated by North America.

In 2023, the 3D bioprinting market in North America secured a prominent share. This achievement was driven by technological progress, escalating research and development undertakings, and improvements in healthcare infrastructure. Furthermore, the region's substantial healthcare spending, the increasing elderly demographic, and the rising prevalence of chronic ailments are all factors boosting the adoption of this technology, particularly within the pharmaceutical sector. Additionally, the year 2021 witnessed an approximate count of 90,000 kidney patients awaiting transplants in the United States, with only 21.4% of them successfully receiving a kidney transplant. Correspondingly, the number of individuals on waiting lists for liver, heart, and lung transplants continues to rise within the country. According to official government statistics, the total tally of individuals awaiting organ transplants exceeded 105,000 in 2021. Moreover, North America is observing a rapid surge in its elderly population along with a heightened incidence of orthopedic conditions. These factors are expected to contribute to the growing demand for bio-printed tissues in the region.

On the other hand, the Asia-Pacific region is poised to emerge as the swiftest-expanding market for 3D bioprinting, primarily driven by its substantial consumer base, escalating research and development endeavors in this field, and governmental support coupled with tax incentives. Notably, Chinese researchers have achieved significant progress in this technology, exemplified by the liquid-in-liquid printing process. This approach involves the combination of liquid polymers to produce a stable membrane. These researchers affirm that the resultant liquid structures can retain their form for up to 10 days before undergoing fusion. Through this innovative technique, they have successfully 3D printed intricate shapes, further laying the groundwork for the biofabrication of tissues composed of living cells.

The Inkjet Printing Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on technology, the market is segmented stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, laminated object manufacturing, inkjet printing and multi-phase jet solidification. In 2023, the inkjet-based segment dominated the technology segment with a largest share of revenue. This technology facilitates the printing of intricate living organs or tissues on culture substrates, utilizing biomaterials like bio-inks. The prevalent use of inkjet-based printing in the medical domain is a key factor propelling the growth of this segment. This study highlights the research trends in inkjet printing as a bio-applicable technology, particularly in the realms of tissue engineering and drug delivery systems. The inkjet-based segment is expected to experience substantial growth in the forecast period, driven by increasing demand and heightened reliability.

Major Segmentations Are Distributed as follows:

  • By Component
    • 3D Bioprinters
    • Bioinks
  • By Technology
    • Stereolithography
    • Selective Laser Sintering
    • Electron Beam Melting
    • Fused Deposition Modeling
    • Laminated Object Manufacturing
    • Inkjet Printing
    • Multi-phase Jet Solidification
  • By Materials
    • Living Cells
    • Extracellular Matrices
    • Hydrogels
  • By Application
    • Surgical Simulation and Training Models
    • Prosthetic Devices
    • Tissue Engineering and Regenerative Medicine
    • Orthopedic Implants
    • Dental Implants
    • Medical Sensors
    • Others
  • By End user
    • Research Organizations & Academic Institutes
    • Biopharmaceutical companies
    • Hospitals
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • U.K.
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of MEA

Recent Developments

  • In April 2023, Organovo announced that it obtained FDA clearance for its bioengineered liver tissue created through 3D printing, marking the inaugural instance of an FDA-cleared 3D-printed human tissue product. The approved tissue is intended for applications in drug discovery and development.
  • In July 2022, Eli Lilly & Corporation, a renowned global pharmaceutical company, had collaborated with Triastek, Inc. to harness the capabilities of 3D printing technology. The primary objective of this partnership was to concentrate on the customized release of drugs in the gastrointestinal tract. Triastek played a key role in ensuring drug stability throughout the formulation development, 3D printing, and drug release phases by conducting a comprehensive examination of excipient quality and process parameters.

Answers to Following Key Questions:

  • What will be the 3D Bioprinting Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of 3D Bioprinting Market?
  • What are the main forces behind worldwide 3D Bioprinting Market? Which companies dominate 3D Bioprinting Market?
  • Which companies dominate 3D Bioprinting Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global Insight Engines industry's suppliers' opportunities and dangers in 3D Bioprinting Market?
  • What is the Insight Engines industry's regional sales, income, and pricing analysis? In the 3D Bioprinting Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the 3D Bioprinting Market?
  • What are the main geographical areas for various industries that are anticipated to observe astounding expansion for 3D Bioprinting Market?
  • What are the dominant revenue-generating regions for 3D Bioprinting Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main 3D Bioprinting Market trends that are influencing the market's expansion?
  • Which key product categories dominate 3D Bioprinting Market? What is 3D Bioprinting Market’s main applications?
  • In the coming years, which 3D Bioprinting Market technology will dominate the market?

 

Reason to purchase this 3D Bioprinting Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global 3D Bioprinting Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different 3D Bioprinting Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global 3D Bioprinting Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global 3D Bioprinting Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top 3D Bioprinting Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.

 

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
  3. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  4. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
  5. 3D Bioprinting Market, By Component
    1. Introduction
    2. 3D Bioprinters
    3. Bioinks
  6. 3D Bioprinting Market, By Technology
    1. Introduction
    2. Stereolithography
    3. Selective Laser Sintering
    4. Electron Beam Melting
    5. Fused Deposition Modeling
    6. Laminated Object Manufacturing
    7. Inkjet Printing
    8. Multi-phase Jet Solidification
  7. 3D Bioprinting Market, By Materials 
    1. Introduction
    2. Living Cells
    3. Extracellular Matrices
    4. Hydrogels
  8. 3D Bioprinting Market, By Application
    1. Introduction
    2. Surgical Simulation and Training Models
    3. Prosthetic Devices
    4. Tissue Engineering and Regenerative Medicine
    5. Orthopedic Implants
    6. Dental Implants
    7. Medical Sensors
    8. Others 
  9. 3D Bioprinting Market, By End user 
    1. Introduction
    2. Research Organizations & Academic Institutes
    3. Biopharmaceutical companies
    4. Hospitals
    5. Others
  10. 3D Bioprinting Market, By Geography
    1. North America
      1. U.S.
      2. Canada
    2. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Rest of the world (RoW)
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  11. Competitive Landscapes
    1. Introduction
    2. Top Companies Ranking
    3. Market Share Analysis
      1. Competition Dashboard
      2. Market Share Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. Envisiontec, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Organovo
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Inventia Life Science Pty Ltd
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
        6. Rewards & Recognition
      4. Poietis
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. Vivax Bio, LLCs
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. Allevi
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. Cyfuse Biomedical K.K.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. 3D Bioprinting Solutions
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. Cellink Global
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. Regemat 3D S.L.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. BICO Group AB
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. Organovo Holdings Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. CollPlant Biotechnologies Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. Aspect Biosystems Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. Advanced Solutions Life Sciences, LLC
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      16. Regenovo Biotechnology Co., Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

3D Bioprinting Market
Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com